Related Overviews


'fludarabine' can also refer to...


Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia

The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy

Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin?

Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia

Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma

Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study

Fludarabine and mitoxantrone: Effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders

Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas

Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy

Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia

Myelodysplastic Syndrome with Complex Karyotypic Abnormality in a Patient with Waldenström's Macroglobulinemia after Sequential Treatment with Chlorambucil and Fludarabine

Alemtuzumab, Fludarabine and Melphalan as a Conditioning Therapy in Severe Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome—Single Center Experience

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication

Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma

Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: A GELA study


More Like This

Show all results sharing this subject:

  • Medicine and Health


Show Summary Details

Quick Reference

A derivative of vidarabine, an antiviral adenosine analogue, that is less susceptible to inactivation by adenosine deaminase. The active metabolite is 2-fluoro-ara-ATP which inhibits DNA polymerase α, ribonucleotide reductase and DNA primase. Used for treatment of adults with B-cell chronic lymphocytic leukaemia that has not responded to other drugs.

Subjects: Medicine and Health.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.